SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals[Amend]
SEC Accession No. 0000215457-16-001666
Filing Date
2016-01-08
Accepted
2016-01-08 17:08:37
Documents
1
Filing Date Changed
2016-01-08

Document Format Files

Seq Description Document Type Size
1 pdl.biopharma.inc..txt SC 13G/A 11504
  Complete submission text file 0000215457-16-001666.txt   13333
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Subject) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43256 | Film No.: 161334165
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

IRS No.: 320174431 | State of Incorp.: DE | Fiscal Year End: 0226
Type: SC 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies
Assistant Director 7